# MediView XR, Inc.

> MediView XR is a Cleveland, Ohio med-tech company building augmented-reality 'X-ray vision' for surgeons. Founded in 2017 on Cleveland Clinic intellectual property, MediView's FDA-cleared XR90 platform and OmnifyXR Interventional Suite let clinicians see a patient's 3D anatomy - bone, tissue, organs, and vasculature - holographically projected through the skin during minimally invasive, ultrasound-guided procedures. Backed by GE HealthCare, Mayo Clinic, and Cleveland Clinic, the company raised a $24M Series A in October 2025.

- **Founded:** 2017
- **Headquarters:** Cleveland, Ohio, United States
- **Founders:** John W. Black (Co-Founder), Adam E. Rakestraw (Co-Founder), Mina Fahim (CEO & President)
- **Team size:** 54 employees
- **Products:** XR90 System, OmnifyXR Interventional Suite
- **Notable:** First 510(k) FDA clearance (July 2023) for an AR device using live imaging combined with 3D XR visualization for pre- and intra-operative use., Performed the first worldwide clinical case with FDA-cleared XR90 at NewYork-Presbyterian/Weill Cornell Medicine., Founded on Cleveland Clinic-developed IP including issued patents.

## Products & services

- **XR90 System** — A first-in-class, FDA 510(k)-cleared AR visualization and navigation platform for minimally invasive, needle-based, ultrasound-guided soft tissue and bone procedures. Provides 3D 'X-ray vision' with CT-based holographic anatomy, live ultrasound projected anatomically into the patient, and a Holographic Light Ray that tracks the physician's instrument.
- **OmnifyXR Interventional Suite** — An interventional augmented-reality solution that fits into existing interventional suites, leveraging AR to support workflow efficiency, ergonomics, and a holographic heads-up display for image-guided procedures.

## Achievements

- First 510(k) FDA clearance (July 2023) for an AR device using live imaging combined with 3D XR visualization for pre- and intra-operative use.
- Performed the first worldwide clinical case with FDA-cleared XR90 at NewYork-Presbyterian/Weill Cornell Medicine.
- Founded on Cleveland Clinic-developed IP including issued patents.
- Closed $24M Series A led by GE HealthCare with Cleveland Clinic and Mayo Clinic participating.
- Launched a multicenter study validating XR90 surgical navigation for soft tissue biopsy.

## Latest updates

- **2025-10** — Closed $24M Series A led by GE HealthCare to expand commercial and clinical adoption.
- **2025** — Launched multicenter study validating XR90 surgical navigation for soft tissue biopsy.
- **2023-12** — Announced first clinical use of FDA-cleared XR90 platform.
- **2023-07** — Received FDA 510(k) clearance for the XR90 AR-based visualization and navigation platform.

## Links

- Website: https://mediview.com
- LinkedIn: https://www.linkedin.com/company/mediview-xr-inc
- Twitter/X: https://twitter.com/mediviewxr
- Facebook: https://facebook.com/MediViewXR/

---

Profile page: https://yespress.io/mediview-xr-inc
Published by YesPress — https://yespress.io
Last updated: 2026-06-08